An 8-week, Multicenter, Randomized, Double-blind, Factorial Phase II Study to Evaluate Dose-response Relationship of Amlodipine and Losartan Combination in Patients With Essential Hypertension.
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2012
At a glance
- Drugs Amlodipine; Amlodipine/losartan; Losartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 01 Feb 2012 Results published in the American Journal of Cardiovascular Drugs.
- 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
- 25 Jul 2009 New trial record